Inoperable Or Metastatic Tumors - Calando Pharmaceuticals Announces Completion Of IT-101 Phase 1 Clinical Study

Inoperable Or Metastatic Tumors - Calando Pharmaceuticals Announces Completion Of IT-101 Phase 1 Clinical Study
Calando Pharmaceuticals, a majority-owned subsidiary of Arrowhead Research Corporation (NASDAQ:ARWR), announced today completion of the IT-101 Phase I clinical study conducted at City of Hope in Duarte, California. The company expects the entire study data to be published in early 2009. IT-101 is an experimental, nanoparticle therapeutic that consists of the drug camptothecin (CPT) conjugated to a cyclodextrin polymer.

Cancer Drug Vidaza(R) Receives Positive Opinion From European Regulatory Authority For Treatment Of MDS And AML
The positive opinion includes important survival data from the AZA-001 trial in higher-risk MDS patients. The CHMP, which reviews applications for all 27 Member States in the European Union (EU) as well as Norway and Iceland, has recommended approval for azacitidine. The CHMP's positive opinion will be forwarded to the European Commission, which generally follows the recommendation of the CHMP and typically issues final marketing approval within two to three months.

Preventing And-Or Recovering From Cancer

With all the vitamin and mineral supplements and other compounds that have been part of almost any health promotion, it's possible that this question in all its simplicity may not have been given its due importance. To what degree is it really possible to EAT your way to good health? I know it's a loaded question, but brushing aside all the sub-questions that I am sure you can think of, in my opinion, foods are far more powerful than we are used to giving them credit for.

Mechanism In Cells That Generate Malignant Brain Tumors May Offer Target For Gene Therapy

Mechanism In Cells That Generate Malignant Brain Tumors May Offer Target For Gene Therapy
Researchers at Cedars-Sinai Medical Center's Maxine Dunitz Neurosurgical Institute who first isolated cancer stem cells in adult brain tumors in 2004 have now identified a molecular mechanism that is involved in the development of these cells from which malignant brain tumors may originate. This could offer a target for scientists seeking treatments that would kill malignant brain tumors at their source and prevent them from recurring.

How Healthy Is John McCain?
A correspondence article published in a recent edition of The Lancet probes the issue of US presidential candidate John McCain's health. The senator from Arizona has a history of the skin cancer melanoma, and there has been much debate in the media regarding the age and health of the 72-year-old.

Erectile Dysfunction May Predict Heart Attacks
An expert has written an article on bmj.com that suggests a link between heart attacks and erectile dysfunction. Dr Geoffrey Hackett (Good Hope Hospital, Birmingham, UK) says that erectile dysfunction gives a two to three year early warning of a heart attack, but doctors are largely ignoring the relationship.

Even Mild Sleep Apnea Increases Cardiovascular Risk
People with even minimally symptomatic obstructive sleep apnea (OSA) may be at increased risk for cardiovascular disease because of impaired endothelial function and increased arterial stiffness, according to a study from the Oxford Centre for Respiratory Medicine in the UK.

Local Research Foundation Achieves Milestone In Fight Against Cancer
Almost everyone knows the devastation that cancer brings to families, workplaces and communities, and many Houstonians are aware of well-known local cancer treatment institutions. Few, however, may be familiar with the CHRISTUS Stehlin Foundation for Cancer Research, a nationally recognized leader in cancer research located in Houston, which recently achieved a milestone in their battle against cancer.